We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Remission of late-onset post-heart transplantation lymphoproliferative disorder following treatment with rituximab and modified mini-CHOP chemotherapy: A case report.
- Authors
QIANG HUANG; TIANXIN YANG; XING JIN; XUMING NI; HAIYAN QI; ZHIKUN YAN
- Abstract
Post-transplant lymphoproliferative disorder (PTLD) is one of the most frequent secondary malignancies that can follow immunosuppressive therapy for solid organ transplantation, and may result in severe morbidities and even mortality. A middle-aged Han Chinese patient, prescribed with immunosuppressive cyclosporine and prednisone, developed PTLD that manifested as a painless cervical lymph node enlargement, 12 years following heart transplantation. Histology revealed monomorphic B-cell PTLD (diffuse large-cell lymphoma); as a result the immunosuppressive regimen of the patient was changed to tacrolimus and mycophenolate mofetil. In addition, the patient was changed to 6-cycle rituximab with a modified mini-CHOP (R-mini-CHOP) regimen for induction, and 8-cycle quarterly rituximab treatment and maintenance therapy. R-mini-CHOP therapy was well tolerated, and no allograft rejection occurred. The patient exhibited clinical remission as demonstrated by the results of the positron emission tomography-computed tomography at the 5-year follow-up visit following R-mini-CHOP therapy. In conclusion, R-mini-CHOP therapy following reduced immunosuppression is effective and safe for the treatment of late-onset PTLD following heart transplantation.
- Subjects
IMMUNOSUPPRESSIVE agents; HEART transplantation; CYCLOSPORINE; PREDNISONE; POSITRON emission tomography
- Publication
Experimental & Therapeutic Medicine, 2016, Vol 12, Issue 1, p262
- ISSN
1792-0981
- Publication type
Case Study
- DOI
10.3892/etm.2016.3310